Bharat Parenterals Ltd

₹ 1,506 1.08%

21 Nov 3:29 p.m.

About

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations^[1]

Key Points

Business Overview:^[1]
BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form of Tablets, Capsules, Liquid- orals, Ointments, Creams, Lotions, and most importantly Powdered Injections and small Volume Parenterals both in Ampoules and Vials.

Website BSE

Market Cap ₹ 983 Cr.
Current Price ₹ 1,506
High / Low ₹ 1,854 / 554
Stock P/E 38.1
Book Value ₹ 496
Dividend Yield 0.07 %
ROCE 13.0 %
ROE 11.2 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Stock is trading at 3.02 times its book value
Promoter holding has decreased over last quarter: -6.07%
The company has delivered a poor sales growth of 2.96% over past five years.
Company has a low return on equity of 12.0% over last 3 years.
Earnings include an other income of Rs.14.1 Cr.
Dividend payout has been low at 1.45% of profits over last 3 years
Company has high debtors of 201 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	60.40	38.46	52.31	26.09	81.90	59.02	50.97	69.91	59.81	58.80	65.64	92.06	64.45
	50.21	35.62	47.77	24.16	72.56	55.51	44.38	58.42	53.38	52.02	61.90	77.07	58.79
Operating Profit	10.19	2.84	4.54	1.93	9.34	3.51	6.59	11.49	6.43	6.78	3.74	14.99	5.66
OPM %	16.87%	7.38%	8.68%	7.40%	11.40%	5.95%	12.93%	16.44%	10.75%	11.53%	5.70%	16.28%	8.78%
	2.52	1.37	2.14	1.54	6.39	3.95	6.96	2.86	3.46	2.40	3.24	3.90	4.60
Interest	0.22	0.21	0.31	0.25	0.34	0.79	0.80	0.88	0.61	0.61	1.09	1.02	0.88
Depreciation	1.72	1.64	1.56	1.54	1.45	1.43	1.43	1.51	1.61	1.67	1.61	1.61	1.75
Profit before tax	10.77	2.36	4.81	1.68	13.94	5.24	11.32	11.96	7.67	6.90	4.28	16.26	7.63
Tax %	25.53%	38.14%	15.59%	25.60%	28.34%	27.29%	17.93%	25.67%	27.51%	26.52%	28.27%	25.09%	28.05%
	8.02	1.46	4.06	1.25	9.99	3.81	9.29	8.89	5.56	5.07	3.07	12.18	5.49
EPS in Rs	14.00	2.55	7.03	2.16	17.30	6.60	16.09	15.39	9.55	8.71	5.28	18.67	8.41
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	95	114	119	125	111	136	220	226	204	212	218	254	281
	86	102	108	114	104	123	189	196	179	183	196	225	250
Operating Profit	9	12	11	10	7	13	30	30	25	29	22	29	31
OPM %	10%	10%	9%	8%	6%	10%	14%	13%	12%	14%	10%	11%	11%
	3	-1	4	5	8	7	13	11	9	7	19	12	14
Interest	1	1	2	1	1	1	1	1	1	1	3	4	4
Depreciation	3	3	4	4	6	6	6	6	6	7	6	6	7
Profit before tax	8	6	9	9	8	14	36	35	27	28	32	31	35
Tax %	10%	-3%	15%	31%	7%	27%	37%	25%	25%	25%	24%	27%
	7	7	7	6	7	10	23	26	20	21	24	23	26
EPS in Rs	12.93	11.43	12.98	11.26	12.88	17.63	39.39	45.90	35.27	36.89	42.15	38.82	41.07
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	2%	3%

Compounded Sales Growth
10 Years:	8%
5 Years:	3%
3 Years:	8%
TTM:	17%

Compounded Profit Growth
10 Years:	9%
5 Years:	0%
3 Years:	4%
TTM:	-6%

Stock Price CAGR
10 Years:	%
5 Years:	52%
3 Years:	61%
1 Year:	162%

Return on Equity
10 Years:	15%
5 Years:	14%
3 Years:	12%
Last Year:	11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6	7
Reserves	30	37	44	51	58	69	91	117	138	160	185	208	317
	14	21	16	19	6	9	5	1	12	15	46	83	42
	26	37	50	44	40	50	60	68	40	37	71	91	97
Total Liabilities	76	101	116	120	111	133	161	192	196	218	308	387	463
	23	29	29	35	31	34	35	33	45	41	36	39	43
CWIP	0	0	0	0	0	0	1	12	0	1	0	0	0
Investments	0	0	0	0	1	1	2	0	42	16	38	49	113
	53	72	87	85	79	99	123	147	110	160	233	299	306
Total Assets	76	101	116	120	111	133	161	192	196	218	308	387	463

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-2	5	-2	6	20	14	22	-22	-12	-23
	-5	-8	-2	-8	-9	-13	-41	22	-14	-16
	7	6	-8	4	-4	-3	11	2	29	34
Net Cash Flow	1	2	-11	2	7	-1	-8	2	3	-5

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	76	126	179	129	144	158	109	132	122	126	188	201
Inventory Days	111	70	55	62	69	60	55	69	61	56	100	125
Days Payable	95	119	188	171	167	110	82	106	71	60	127	123
Cash Conversion Cycle	91	77	47	20	46	108	82	95	111	122	161	204
Working Capital Days	74	67	72	45	65	95	81	97	118	159	163	182
ROCE %	21%	18%	17%	15%	12%	19%	40%	32%	20%	18%	14%	13%

Shareholding Pattern

Numbers in percentages

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Oct 2024
	73.84%	73.84%	73.84%	73.84%	73.84%	73.84%	73.84%	73.84%	73.27%	73.27%	65.35%	67.20%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.08%	0.08%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.57%	0.54%
	26.15%	26.15%	26.16%	26.16%	26.15%	26.16%	26.15%	26.15%	26.72%	26.72%	33.98%	32.17%
No. of Shareholders	2,796	2,765	2,700	2,608	2,515	2,485	2,481	2,397	2,497	2,708	2,748	2,750

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Oct 2024
	74.42%	74.42%	74.42%	74.42%	73.84%	73.84%	73.27%	67.20%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.08%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.54%
	25.57%	25.57%	25.57%	25.57%	26.15%	26.15%	26.72%	32.17%
No. of Shareholders	1,422	1,447	1,471	2,572	2,796	2,515	2,497	2,750

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Bharat Parenterals Ltd

Bharat Parenterals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Concalls